Pharmacology Update for the Treatment of Hepatitis C Virus

Hopkins, Leslie W.; Dunlap, Travis; Cline, Holly

doi:10.1016/j.cnur.2020.06.008

Cited by 2 publications

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Advancement of oral DAA therapies has resulted in a paradigm shift in treating HCV, with cure rates of > 90% and few adverse effects. DAAs with pan genotypic activity are recommended as preferred regimens for all treatment-naïve and treatment-experienced HCV patients, regardless of age, sex, stage of liver fibrosis, or HIV coinfection[ 93 , 99 , 100 ]. Conversely, pegylated-interferon-based regimens are no longer recommended.…”

Section: Hepatitis C Virusmentioning

confidence: 99%

Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030

Sintusek¹,

Thanapirom²,

Komolmit³

et al. 2022

WJG

View full text Add to dashboard Cite

Viral hepatitis infections are a great burden in children who have received liver transplant. Hepatotropic viruses can cause liver inflammation that can develop into liver graft fibrosis and cirrhosis over the long term. Immunological reactions due to viral hepatitis infections are associated with or can mimic graft rejection, rendering the condition difficult to manage. Prevention strategies using vaccinations are agreeable to patients, safe, cost-effective and practical. Hence, strategies to eliminate viral hepatitis A and B focus mainly on immunization programmes for children who have received a liver transplant. Although a vaccine has been developed to prevent hepatitis C and E viruses, its use is not licensed worldwide. Consequently, eliminating hepatitis C and E viruses mainly involves early detection in children with suspected cases and effective treatment with antiviral therapy. Good hygiene and sanitation are also important to prevent hepatitis A and E infections. Donor blood products and liver grafts should be screened for hepatitis B, C and E in children who are undergoing liver transplantation. Future research on early detection of viral hepatitis infections should include molecular techniques for detecting hepatitis B and E. Moreover, novel antiviral drugs for eradicating viral hepatitis that are highly effective and safe are needed for children who have undergone liver transplantation.

show abstract

Section: Hepatitis C Virusmentioning

confidence: 99%